Lamberto Andreotti

Type: Person
Name: Lamberto Andreotti
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Editor’s Note: Digging Deeper

Bill Hatton Editorial DirectorWe dig deep with a variety of companies to bring you the following lineup this issue:• Bristol-Myers Squibb topped our 100 Best Corporate Citizens list. Our CEO Elliot Clark and I sat down in BMS CEO Lamberto Andreotti’s ... [Published CRO - 7 hours ago]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

BMS, Pfizer pull out all the stops to give Eliquis sales a Q2 jolt

Eliquis, Pfizer and Bristol-Myers Squibb's new-age anticoagulant, got off to somewhat of a rocky start. The third entrant in the warfarin replacement market, the drug lagged well behind competitors last year, with EP Vantage in October estimating that ... [Published FiercePharma - Aug 13 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

BMS, Ono Pharma sign pact to develop and commercialise Opdivo and Yervoy across broad range of tumour types

Bristol-Myers Squibb Company (BMS) and Ono Pharmaceutical Co, an R&D-oriented pharmaceutical company, have signed a strategic collaboration agreement to jointly develop and commercialise multiple immunotherapies as single agents and combination regimens ... [Published PharmaBiz - Jul 25 2014]
First reported Apr 30 2014 - Updated Apr 30 2014 - 1 reports

Bristol-Myers Squibb's (BMY) CEO John Elicker on Q1 2014 Earnings - Call Transcript

This transcript originally appeared on Seeking Alpha.Title: Bristol-Myers Squibb's CEO Discusses Q1 2014 Results - Earnings Call Transcript Symbol: BMYCall Start: 09:00Call End: 09:58Bristol-Myers Squibb Company (BMY)Q1 2014 Earnings Conference CallApril ... [Published The Street Latest - Apr 30 2014]
First reported Apr 30 2014 - Updated Apr 30 2014 - 1 reports

Bristol-Myers Squibb net earnings up by 54% in Q1

Bristol-Myers Squibb has posted strong growth in its net earnings during the first quarter ended March 2014 despite lower sales. The net earnings improved by 53.9 per cent to US$ 937 million from $609 million in the similar quarter of last year with significant ... [Published PharmaBiz - Apr 30 2014]

More Content

All (8) | News (8) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Editor’s Note: Digging Deeper [Published CRO - 7 hours ago]
BMS, Pfizer pull out all the stops to give Eliq... [Published FiercePharma - Aug 13 2014]
BMS, Ono Pharma sign pact to develop and commer... [Published PharmaBiz - Jul 25 2014]
Bristol-Myers Squibb's (BMY) CEO John Elicker o... [Published The Street Latest - Apr 30 2014]
Bristol-Myers Squibb net earnings up by 54% in Q1 [Published PharmaBiz - Apr 30 2014]
Product Positioning 2.0 [Published Pharmaceutical Executive - Feb 05 2014]
Bristol-Myers Squibb net falls by 21.5% in Q4 [Published PharmaBiz - Jan 27 2014]
J.P. Morgan: Pharma’s Agenda for 2014 [Published Pharmaceutical Executive - Jan 20 2014]
1
In Focus
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.